Classification and Regression Tree Analysis of Clinical Patterns that Predict Survival in 127 Chinese Patients with Advanced Non-small Cell Lung Cancer Treated by Gefitinib Who Failed to Previous Chemotherapy

Classification and Regression Tree Analysis of Clinical Patterns that Predict Survival in 127 Chinese Patients with Advanced Non-small Cell Lung Cancer Treated by Gefitinib Who Failed to Previous Chemotherapy

Background and objective It has been proven that gefitinib produces only 10%-20% tumor regression in heavily pretreated, unselected non-small cell lung cancer (NSCLC) patients as the second- and third-line setting. Asian, female, nonsmokers and adenocarcinoma are favorable factors; however, it is di...

Full description

Bibliographic Details
Main Authors: Ziping WANG, Jihong GUO, Yan WANG, Yutao LIU, Juan YANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2011-09-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Gefitinib
Classification and regression tree (CART)
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2011.09.04

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2011.09.04

Similar Items